A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

OBJECTIVE: Vulvovaginal atrophy (VVA) is characterized by vaginal changes, dyspareunia, and itching/irritation. Efficacy and safety of a lower-dose estradiol vaginal cream (0.003%) were evaluated in postmenopausal women with VVA-related dyspareunia. METHODS: This was a phase 3, randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroll, Robin, Archer, David F., Lin, Yuhua, Sniukiene, Vilma, Liu, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779318/
https://www.ncbi.nlm.nih.gov/pubmed/28926514
http://dx.doi.org/10.1097/GME.0000000000000985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779318/
https://www.ncbi.nlm.nih.gov/pubmed/28926514
http://dx.doi.org/10.1097/GME.0000000000000985

Ejemplares similares